These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 17514802)
41. Autologous stem-cell transplantation in multiple myeloma. Gahrton G Wien Med Wochenschr; 1995; 145(2-3):52-4. PubMed ID: 7762254 [TBL] [Abstract][Full Text] [Related]
42. Current status of autologous hematopoietic stem cell transplantation in myeloma. Mehta J; Singhal S Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S28-S34. PubMed ID: 18724294 [TBL] [Abstract][Full Text] [Related]
45. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Porrata LF; Gertz MA; Geyer SM; Litzow MR; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Lacy MQ; Dispenzieri A; Snow DS; Markovic SN Leukemia; 2004 Jun; 18(6):1085-92. PubMed ID: 15042106 [TBL] [Abstract][Full Text] [Related]
46. Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents. Cook G Bone Marrow Transplant; 2015 Oct; 50(10):1269-70. PubMed ID: 26237169 [No Abstract] [Full Text] [Related]
47. A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center. Mohyuddin GR; Faisal MS; Badar T; Shah N; Bashir Q; Patel KK; Hosing C; Popat UR; Rondon G; Delgado R; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Orlowski RZ; Champlin RE; Qazilbash MH Leuk Lymphoma; 2018 Feb; 59(2):515-518. PubMed ID: 28673185 [No Abstract] [Full Text] [Related]
48. Recovery of renal function after autologous stem cell transplantation in myeloma patients with end-stage renal failure. Tauro S; Clark FJ; Duncan N; Lipkin G; Richards N; Mahendra P Bone Marrow Transplant; 2002 Oct; 30(7):471-3. PubMed ID: 12368962 [TBL] [Abstract][Full Text] [Related]
49. Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma. Rosko A; Hofmeister C; Benson D; Efebera Y; Huang Y; Gillahan J; Byrd JC; Burd CE Bone Marrow Transplant; 2015 Oct; 50(10):1379-81. PubMed ID: 26121107 [No Abstract] [Full Text] [Related]
50. The role of autologous stem cell transplantation in the management of multiple myeloma. Fermand JP; Brechignac S Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889 [TBL] [Abstract][Full Text] [Related]
51. Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis. Kawamura K; Ikeda T; Hagiwara S; Mori T; Shinagawa A; Nishiwaki K; Ohashi K; Kubonishi S; Fukuda T; Ito T; Tomita N; Ichinohe T; Kato K; Morishima Y; Atsuta Y; Sunami K; Kanda Y Leuk Lymphoma; 2016 Sep; 57(9):2077-83. PubMed ID: 26961137 [TBL] [Abstract][Full Text] [Related]
52. Advances in the treatment of multiple myeloma. Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186 [No Abstract] [Full Text] [Related]
53. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma. Nishihori T; Alsina M Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244 [TBL] [Abstract][Full Text] [Related]
56. Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients. Michallet M; Sobh M; El-Cheikh J; Morisset S; Sirvent A; Reman O; Cornillon J; Tabrizi R; Milpied N; Harousseau JL; Labussière H; Nicolini FE; Attal M; Moreau P; Mohty M; Blaise D; Avet-Loiseau H Exp Hematol; 2013 Dec; 41(12):1008-15. PubMed ID: 23994781 [TBL] [Abstract][Full Text] [Related]
57. Allogeneic hematopoietic stem-cell transplantation for myeloma: it's time for the appropriate studies. Gratwohl A J Clin Oncol; 2011 Jun; 29(16):e483; author reply e484. PubMed ID: 21464404 [No Abstract] [Full Text] [Related]
58. Autologous hematopoietic stem-cell transplantation for multiple myeloma. Harousseau JL; Moreau P N Engl J Med; 2009 Jun; 360(25):2645-54. PubMed ID: 19535803 [No Abstract] [Full Text] [Related]
59. When to recommend a second autograft in patients with relapsed myeloma? Ziogas DC; Terpos E; Dimopoulos MA Leuk Lymphoma; 2017 Apr; 58(4):781-787. PubMed ID: 27894207 [TBL] [Abstract][Full Text] [Related]
60. Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma. Giaccone L; Evangelista A; Patriarca F; Sorasio R; Pini M; Carnevale-Schianca F; Festuccia M; Brunello L; Zallio F; Maffini E; Omedé P; Bringhen S; Mordini N; Fanin R; Ciccone G; Boccadoro M; Bruno B Biol Blood Marrow Transplant; 2018 Jan; 24(1):189-193. PubMed ID: 28987930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]